Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

EONS Poster diplay

3736 - EONS Poster - “It may not affect you” -- Lived experiences and support needs of women who developed peripheral neuropathy following chemotherapy treatment for cancer.


22 Oct 2018


EONS Poster diplay


Management of Systemic Therapy Toxicities;  Supportive Care and Symptom Management

Tumour Site


Mary Tanay


Annals of Oncology (2018) 29 (suppl_8): viii698-viii701. 10.1093/annonc/mdy278


M.A. Tanay1, J. Armes2

Author affiliations

  • 1 Faculty Of Nursing, Midwifery And Palliative Care, King's College London, Se1 8WA - London/GB
  • 2 Faculty Of Health And Medical Sciences, University of Surrey, GU2 7XH - Surrey/GB


Login to access the resources on OncologyPRO.

If you do not have an ESMO account, please create one for free.

Abstract 3736


Some cancer drugs cause chemotherapy-induced peripheral neuropathy (CIPN) or damage to the nerves. CIPN affects the hands and feet, with patients reporting symptoms such as numbness, tingling, pain and muscle weakness. The nature of symptoms depends on the chemotherapy agents and drug dose that patients receive. Options to minimise the severity of symptoms may involve dose reduction, delay or discontinuation of chemotherapy. This study explored lived experiences of women who developed peripheral neuropathy following cancer chemotherapy treatment.


The study was conducted in the United Kingdom and was advertised through cancer charity websites and social media accounts. Using set eligibility criteria, purposeful convenience sampling was carried out. Women diagnosed with breast or ovarian cancer who experienced or are still experiencing neuropathy following chemotherapy treatment were recruited. Semi-structured recorded telephone interviews were conducted (n = 15). Interpretative phenomenological analysis (IPA) was used to analyse data.


The analysis resulted to four main themes: struggle to process CIPN information, information and trust when making treatment decisions, experience of symptom reporting and challenges of mitigating CIPN symptoms. Similar to previous studies, participants used analogies to describe CIPN symptoms such as ‘like walking on pebbles, sand, needles or gravel’.


Findings suggest that interventions to improve understanding of CIPN symptoms by patients and clinicians are needed in practice. A broader insight of patients’ experiences of CIPN helps progress development of interventions to enhance communication, assessment and management of CIPN symptoms.

Clinical trial identification

Legal entity responsible for the study

King's College London.


Has not received any funding.

Editorial Acknowledgement


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.